Bug Bite Thing’s Shark Tank Breakthrough
When Kelley Higney and her mother Ellen McAlister stepped onto the Shark Tank stage in 2019, they weren’t just selling a product—they were offering a solution to a universal annoyance. Their invention, the Bug Bite Thing, is a small suction tool designed to extract insect venom from skin, eliminating the need for chemical creams or home remedies. The duo’s pitch, which aired in Season 11, Episode 4, captured the attention of Lori Greiner, who secured a deal: $150,000 for 10% equity in the company. This moment marked a turning point for Bug Bite Thing, propelling it from a niche product to a household name.
The Shark Tank deal wasn’t just a financial win—it was a marketing catalyst. Sales surged by 300% within six months of the episode’s airing, and the tool began appearing on major retail shelves. By 2026, Bug Bite Thing had evolved into a multi-million-dollar brand, with annual revenue exceeding $5 million and a net worth estimated at $20 million+. This growth is a testament to the product’s unique value proposition and the founders’ strategic vision.
From $2M to $5M+ Revenue: Growth Metrics
The financial trajectory of Bug Bite Thing is a compelling story of exponential growth. In 2018, the company was generating approximately $2 million in annual revenue. By 2026, that figure had more than doubled to $5+ million. This growth can be attributed to several factors: the Shark Tank exposure, strategic retail partnerships (including Target and Walmart), and the product’s appeal to a broad demographic. The tool’s simplicity and effectiveness have made it a staple in households across the United States, particularly during peak bug season.
Revenue growth isn’t the only metric that tells the story of Bug Bite Thing’s success. The company’s net worth, estimated at $20 million+ in 2026, reflects its strong market position. This figure is calculated using a 4x revenue multiple, a common valuation method for small to mid-sized businesses. The founders have also expanded their product line to include eco-friendly materials and are exploring new markets, such as insect-repelling products, which could further boost revenue in the coming years.
The Science Behind the Suction Tool
The Bug Bite Thing’s innovation lies in its scientific approach to a common problem. Unlike traditional chemical-based remedies, the tool uses a suction mechanism to draw out insect venom, reducing swelling and itching. This method is supported by clinical studies showing that suction can effectively mitigate the inflammatory response caused by insect bites. The tool’s design, which includes a patented U.S. Patent #D780,342 (granted in 2017), ensures a secure and comfortable application, making it user-friendly for all ages.
Compared to chemical alternatives like hydrocortisone creams or antihistamines, the Bug Bite Thing offers a non-invasive, chemical-free solution. This appeal has positioned it as a leader in the $2.3 billion global anti-itch market. Health-conscious consumers, in particular, have embraced the product for its safety and efficacy. The tool’s ability to provide instant relief without the risk of skin irritation or chemical side effects is a key differentiator in a crowded market.
Founder Kelley Higney’s Entrepreneurial Journey
Kelley Higney’s journey from a Florida-based mom to a Shark Tank success story is both inspiring and instructive. The idea for Bug Bite Thing was born out of personal frustration. After moving from California to Florida, Higney found herself and her family constantly battling bug bites. This problem, which she describes as “a universal annoyance,” became the catalyst for her entrepreneurial venture. With her mother Ellen McAlister, she developed the suction tool in 2011, testing it on friends and family before launching it as a small business.
Higney’s path was not without challenges. Early on, she faced skepticism from investors and retailers who doubted the product’s potential. However, her persistence paid off when Lori Greiner took a chance on the Shark Tank deal. Since then, Higney has become a vocal advocate for innovation in the health and wellness space. Her story underscores the importance of solving real-world problems and the value of perseverance in entrepreneurship.
Bug Bite Thing vs. Chemical Remedies: Market Position
In a market dominated by chemical-based products, Bug Bite Thing has carved out a unique niche by offering a non-toxic alternative. Competitors like Bite Blocker and Bite Relief Creams rely on active ingredients such as DEET or hydrocortisone, which can cause skin irritation or allergic reactions in some users. Bug Bite Thing, on the other hand, uses a mechanical approach that is safe for all skin types, including sensitive skin. This differentiation has allowed the product to attract a loyal customer base and gain traction in eco-conscious markets.
The company’s retail strategy has also contributed to its success. By securing partnerships with major retailers like Amazon, Target, and Walmart, Bug Bite Thing has ensured widespread accessibility. Additionally, the product’s seasonal demand—peaking during summer and outdoor activities—has created a steady revenue stream. The founders have also leveraged social media and influencer marketing to build brand awareness, further solidifying their position in the market.
Future Goals and Expansion Plans
With a strong foundation in place, Bug Bite Thing is poised for further growth. The company’s 2026 roadmap includes the launch of an eco-friendly product line, designed to appeal to environmentally conscious consumers. This initiative aligns with the founders’ commitment to sustainability and reflects broader market trends toward green innovation. Additionally, the company is exploring the development of insect-repelling products, which could expand its reach beyond bite relief into preventive care.
Internationally, Bug Bite Thing is eyeing markets in Europe and Asia, where demand for non-chemical health solutions is growing. The founders have also expressed interest in developing a line of accessories, such as portable storage cases and travel kits, to enhance the user experience. These strategic moves underscore the company’s ambition to become a global leader in the anti-itch market while maintaining its core mission of providing safe, effective solutions.
8 Key Facts About Bug Bite Thing Net Worth
Shark Tank Deal Details
Bug Bite Thing secured a $150,000 investment from Lori Greiner in 2019 for 10% equity. This deal, which aired in Shark Tank Season 11, Episode 4, marked the company’s entry into mainstream retail and significantly boosted its visibility. The deal terms were structured to provide immediate capital while allowing the founders to retain majority control of the business.
Revenue Growth from $2M to $5M+
Pre-Shark Tank revenue in 2018 was approximately $2 million annually. By 2026, the company had achieved $5+ million in annual revenue, driven by increased retail partnerships and direct-to-consumer sales. This growth reflects the product’s widespread adoption and its appeal to both casual users and outdoor enthusiasts.
Net Worth Estimation
Bug Bite Thing’s net worth is estimated at $20 million+ in 2026, calculated using a 4x revenue multiple. This valuation is based on industry benchmarks for small to mid-sized businesses and accounts for the company’s strong brand equity and market position.
Patent and Legal Protection
The Bug Bite Thing tool is protected by U.S. Patent #D780,342, granted in 2017. This design patent ensures the product’s unique suction mechanism is legally protected from imitation, giving the company a competitive edge in the market.
Market Size and Competition
The global anti-itch market is valued at $2.3 billion, with Bug Bite Thing capturing a growing share through its chemical-free approach. Competitors like Bite Blocker and hydrocortisone creams remain dominant, but the product’s safety profile and ease of use are key differentiators.
Retail Strategy
Bug Bite Thing is available through major retailers, including Amazon, Target, and Walmart. This multi-channel strategy ensures the product reaches a broad audience while maintaining control over pricing and distribution.
Future Expansion Plans
The company plans to launch an eco-friendly product line in 2026 and expand into insect-repelling products. These initiatives align with market trends and are expected to drive revenue growth in the coming years.
Founder Backgrounds
Kelley Higney and Ellen McAlister, the founders, developed the product in 2011 after moving from California to Florida. Their mother-daughter partnership combines personal experience with entrepreneurial expertise, creating a unique story of innovation and resilience.
Data Tables
| Year | Revenue (USD) | Net Worth Estimate (USD) |
|---|---|---|
| 2018 | $2,000,000 | $8,000,000 |
| 2026 | $5,000,000+ | $20,000,000+ |
| Competitor | Product Type | Key Differentiator |
|---|---|---|
| Bite Blocker | Spray | Contains DEET |
| Bite Relief Cream | Cream | Hydrocortisone-based |
| Bug Bite Thing | Suction Tool | Chemical-free, patented design |
Did You Know?
The Bug Bite Thing tool’s patented suction mechanism (U.S. Patent #D780,342) is based on clinical research showing that mechanical extraction of insect venom can reduce inflammation and itching. This scientific approach sets it apart from traditional chemical remedies and highlights its role in the $2.3 billion global anti-itch market.
FAQ: Bug Bite Thing Net Worth and Beyond
How Much Is Bug Bite Thing Worth in 2026?
Bug Bite Thing’s net worth is estimated at $20 million+ in 2026. This valuation is based on a 4x revenue multiple and reflects the company’s strong market position and growth trajectory.
Did Bug Bite Thing Secure a Deal on Shark Tank?
Yes, Bug Bite Thing secured a $150,000 investment from Lori Greiner in 2019 for 10% equity. This deal, which aired in Shark Tank Season 11, Episode 4, significantly boosted the company’s visibility and revenue.
How Does the Bug Bite Thing Tool Work?
The tool uses a suction mechanism to extract insect venom from the skin, reducing swelling and itching. This chemical-free approach is supported by clinical research and is safe for all skin types.
What Is the Annual Revenue of Bug Bite Thing?
Bug Bite Thing generates $5+ million in annual revenue as of 2026. This growth is driven by retail partnerships and direct-to-consumer sales, particularly during peak bug season.
Who Are the Founders of Bug Bite Thing?
The founders are Kelley Higney and her mother Ellen McAlister. They developed the product in 2011 after moving from California to Florida and faced significant challenges before securing the Shark Tank deal.
Are There Competitors to Bug Bite Thing?
Yes, competitors include products like Bite Blocker and Bite Relief Creams. However, Bug Bite Thing’s chemical-free suction tool and patented design give it a unique edge in the market.
Where Can I Buy the Bug Bite Thing Tool?
The tool is available through major retailers like Amazon, Target, and Walmart, as well as directly from the company’s website. This multi-channel strategy ensures accessibility for all consumers.
Conclusion: Final Verdict
Bug Bite Thing’s journey from a mother-daughter side hustle to a $20 million+ brand is a testament to the power of innovation and persistence. The company’s success on Shark Tank and subsequent market expansion highlight its ability to solve a universal problem with a simple, effective solution. By combining scientific research with a chemical-free approach, Bug Bite Thing has carved out a unique position in the $2.3 billion anti-itch market.
Looking ahead, the company’s plans for eco-friendly products and insect-repelling solutions suggest a commitment to sustainability and market diversification. For consumers, Bug Bite Thing offers a safe, effective alternative to traditional remedies, while for investors, it represents a promising growth story. Whether you’re battling a mosquito bite on a summer hike or a bee sting at a picnic, Bug Bite Thing’s suction tool is a reminder that sometimes the best solutions are the simplest ones.
